Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma

Glioblastoma (GBM) is the most malignant and aggressive form of glioma and is associated with a poor survival rate. Latest generation Tumour Necrosis Factor Related Apoptosis-Inducing Ligand (TRAIL)-based therapeutics potently induce apoptosis in cancer cells, including GBM cells, by binding to deat...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Nivetha Krishna Moorthy, Oliver Seifert, Stephan Eisler, Sara Weirich, Roland E. Kontermann, Markus Rehm, Gavin Fullstone
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: MDPI AG 2021-12-01
Sraith:Molecules
Ábhair:
glioblastoma
TRAIL
angiopep-2
CNS delivery
receptor-mediated transcytosis
blood–brain barrier
Rochtain ar líne:https://www.mdpi.com/1420-3049/26/24/7582

Ar líne

https://www.mdpi.com/1420-3049/26/24/7582

Míreanna comhchosúla